Zosano Pharma

News

Zosano Pharma has been hit by an FDA rejection of its marketing application for migraine drug Qtrypta, asking for new bioequivalence data.

News

Study suggests routine genomic testing could correct well-established disparities in breast cancer survival rates between white and black women.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.